Venous Thromboembolism: all 708 studies
Page 4 of 8. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.
- Venous Thrombo-Embolism Imaging Database (VTE-ID)CompletedNCT06258694
- The Role of Platelet TLRs in Platelet Activation During VTETerminatedNCT06257290
- Pregnancy and Postpartum Period Venous Thromboembolism and SimulationActive, not recruitingNCT06218095Not applicable
- CLEANer Aspiration for Pulmonary EmbolismSuspendedNCT06189313Not applicable
- Glioblastoma Remote Monitoring and Care - Research ProtocolSuspendedNCT06129760Not applicable
- Leiden Thrombosis Recurrence Risk PreventionActive, not recruitingNCT06087952Not applicable
- Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort StudyCompletedNCT06073366
- Complications Related to Vascular Access Devices in Home Parenteral Nutrition PatientsCompletedNCT05948514
- Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 PatientsCompletedNCT05926518
- Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum StudyCompletedNCT05897697
- The Effect of Sock Developed with Wearable Technology for TUR Surgery Patients on Hypothermia and Venous ThromboembolismWithdrawnNCT05887518Not applicable
- Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled TrialCompletedNCT05878899Phase 3
- Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With EnoxaparinTerminatedNCT05819125
- A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical IllnessTerminatedNCT05819112
- SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee ArthroplastyCompletedNCT05752461Phase 2
- DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme InducersActive, not recruitingNCT05750680
- Risk Factors and Prediction Model of Cancer-associated Venous ThromboembolismStatus unknownNCT05729464
- Evaluation of the SCALED (SCaling AcceptabLE cDs)Active, not recruitingNCT05628207
- Venous Thromboembolism (VTE) KnowledgeCompletedNCT05548010
- Thrombosis in Patients With Multiple Myeloma in an University Medical CenterCompletedNCT05541978
- A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood ClotWithdrawnNCT05536791
- Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic EventsCompletedNCT05515120Phase 2/3
- Predicting the Risk of Venous Thromboembolism in Critically Ill PatientsStatus unknownNCT05498142
- Efficacy of ICU-VTE Scale in ICU PatientsCompletedNCT05487066
- VTE and the Related Factors Associated With Higher Rates of PE After a DVT in Southwestern ChinaCompletedNCT05464901
- An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)CompletedNCT05461807
- Risk Factors of Venous Thromboembolism After Incisional Ventral Hernia Repair.CompletedNCT05439187
- Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective StudyActive, not recruitingNCT05396157
- Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous ThromboembolismStatus unknownNCT05382481Not applicable
- Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims DataCompletedNCT05264168
- The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal PatientsWithdrawnNCT05246943
- Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 PatientsCompletedNCT05226793
- Anti-factor Xa Based Venous Thromboembolism ProphylaxisCompletedNCT05221879Not applicable
- Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study)CompletedNCT05209048
- Neuromuscular Stimulation Versus Intermittent Compression for Venous Thromboembolism Prophylaxis in Critical CareCompletedNCT05208216Not applicable
- Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid SyndromeCompletedNCT05195372
- A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee ReplacementStatus unknownNCT05189002Phase 2
- Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19CompletedNCT05185804Phase 3
- A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTETerminatedNCT05171075Phase 3
- A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTETerminatedNCT05171049Phase 3
- A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)CompletedNCT05150938
- Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic ComplicationsCompletedNCT05143567Not applicable
- A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)CompletedNCT05112666
- Sonoclot to Evaluate Thrombotic Risk in Proteinuric PregnancyStatus unknownNCT05108389
- SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD SurgeryWithdrawnNCT05104229Phase 3
- LMWH Compliance in PregnancyStatus unknownNCT05066867
- Low Molecular Weight hEparin vs. Aspirin Post-partumCompletedNCT05058924Not applicable
- Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study)CompletedNCT05058521
- THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)TerminatedNCT05033314Phase 3
- Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs EnoxaparinStatus unknownNCT04999176Phase 3
- Impact of COVID-19 Vaccines on Cerebrovascular HealthCompletedNCT04992195
- Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States CohortCompletedNCT04979780
- the Effectiveness of Different Risk Scales In Predicting VTE in Respiratory InpatientsCompletedNCT04963374
- Effect of the Genotype on Postoperative DVTCompletedNCT04940377
- A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims DatabaseCompletedNCT04923139
- Prevalence of Gynecological Pathologies and Use of Hormonal Treatments in Women Hospitalized for a Venous Thromboembolic EpisodeCompletedNCT04920487
- Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to ApixabanTerminatedNCT04895553
- Venous Thrombosis Virtual Surveillance in COVID-19CompletedNCT04865913
- Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIOCompletedNCT04846556
- Clotting Parameters After Medical AbortionCompletedNCT04824118
- Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS DataCompletedNCT04818151
- A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac SurgeryCompletedNCT04803747Phase 4
- A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill PatientsCompletedNCT04768036Not applicable
- Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual BleedingTerminatedNCT04748393
- Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical TreatmentCompletedNCT04744688
- A Performance Evaluation of the LumiraDx Point Of Care D-dimer AssayCompletedNCT04737954
- Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims DataCompletedNCT04736719
- Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims DataCompletedNCT04736420
- Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims DataCompletedNCT04735523
- Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.TerminatedNCT04710732Phase 4
- Development and Validation of the Patient-completed Caprini Risk ScoreStatus unknownNCT04663477
- Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE TrialCompletedNCT04662684Phase 3
- WHITE Study: WHIch Decision After a First Venous ThromboEmbolism?CompletedNCT04646993
- Anticoagulation in Patients With Venous Thromboembolism and CancerCompletedNCT04618913
- Examining the Experiences of Children With Blood DisordersCompletedNCT04600609
- Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort StudyStatus unknownNCT04588805
- Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) EventsCompletedNCT04574895Not applicable
- COVID-19 and Venous Thromboembolism RiskCompletedNCT04569344
- Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.TerminatedNCT04558892Phase 2/3
- Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer SurgeryCompletedNCT04479579Phase 4
- Clonal Hematopoiesis of Indeterminate Potential in Venous ThromboembolismCompletedNCT04477564
- Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in GermanyCompletedNCT04444804
- A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 PandemicCompletedNCT04444700Phase 3
- Risk Stratification for Venous Thromboembolism in Hospitalized Medical PatientsCompletedNCT04439383
- Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 PandemicCompletedNCT04400877
- Improving Safety of Diagnosis and Therapy in the Inpatient SettingCompletedNCT04393909Not applicable
- Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19CompletedNCT04374617
- Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19CompletedNCT04373707Phase 4
- Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19CompletedNCT04359212
- Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell TraitCompletedNCT04349189
- Cardiovascular Complications and COVID-19 (CovCardioVasc-Study)CompletedNCT04335162
- Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer PatientsStatus unknownNCT04301362
- Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine PhysiciansCompletedNCT04272723
- Efficacy of the Use of Risk Scores in Reducing Important Clinical Outcomes in Hospitalized Medical Ill PatientsCompletedNCT04267718Not applicable
- Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical InpatientsCompletedNCT04257305
- Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm PatientsCompletedNCT04243122Phase 2
- Perioperative Anticoagulant Use for Surgery Evaluation Emergency RegistryCompletedNCT04195113
- The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Safety StudyStatus unknownNCT04179487
- Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs RivaroxabanStatus unknownNCT04169269Phase 4
- A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy VolunteersCompletedNCT04157881Phase 4